GGrantIndex
← Leaderboards

California Medical Innovations Institute

San Diego, CA

Compare ↔
$23,615,085
Total funding
9
Grants

Funding over time

peak $3.8M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$23,615,085 · 9

By mechanism

R01$13,746,662 · 6
OT2$9,868,423 · 3

Investigators at California Medical Innovations Institute

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

All-Time

Most funded here, all years

Largest grants

Fecobionics device for mapping colonic and anorectal neuromuscular function$1,675,013
OT2 · FY2018 · OD
Fecobionics device for mapping colonic and anorectal neuromuscular function$1,556,194
OT2 · FY2019 · OD
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence$1,492,788
OT2 · FY2019 · OD
Mathematical Model-Based Optimization of CRT Response in Ischemia$811,994
R01 · FY2023 · HL
Mathematical Model-Based Optimization of CRT Response in Ischemia$771,198
R01 · FY2025 · HL
Mathematical Model-Based Optimization of CRT Response in Ischemia$765,101
R01 · FY2024 · HL
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$762,766
R01 · FY2022 · DK
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence$755,154
OT2 · FY2021 · OD
SODA - Desktop Software to Enhance the SPARC Data Curation Workflow$733,675
OT2 · FY2021 · OD
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$717,356
R01 · FY2023 · DK
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$700,554
R01 · FY2022 · HL
Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence$696,645
OT2 · FY2021 · OD
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$681,054
R01 · FY2023 · HL
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$681,054
R01 · FY2025 · HL
SODA - Desktop Software to Enhance the SPARC Data Curation Workflow$677,009
OT2 · FY2023 · OD
SODA - Desktop Software to Enhance the SPARC Data Curation Workflow$676,847
OT2 · FY2024 · OD
Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy$667,433
R01 · FY2024 · HL
Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics$652,851
R01 · FY2024 · DK
Defecation mechanisms and subtyping of constipation patients with Fecobionics$647,580
R01 · FY2024 · DK
Defecation mechanisms and subtyping of constipation patients with Fecobionics$645,591
R01 · FY2021 · DK